Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -100,294 | -104,126 | -110,211 | -116,215 | -101,775 |
| Depreciation Amortization | 2,028 | 2,863 | 4,190 | 4,887 | 9,351 |
| Income taxes - deferred | -70 | 0 | N/A | N/A | N/A |
| Accounts receivable | 457 | 588 | -1,028 | 394 | 488 |
| Accounts payable and accrued liabilities | 1,266 | 3,119 | -995 | 10,365 | -5,238 |
| Other Working Capital | 2,292 | 4,973 | -4,821 | 10,213 | 1,008 |
| Other Operating Activity | 18,699 | 1,504 | 18,405 | 2,418 | 13,798 |
| Operating Cash Flow | $-75,622 | $-91,079 | $-94,460 | $-87,938 | $-82,368 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -110,509 | 101,135 | -97,400 | 68,536 | -107,215 |
| PPE Investments | 2,090 | -1,591 | -407 | 1,419 | -1,068 |
| Net Acquisitions | N/A | N/A | N/A | N/A | -5,561 |
| Investing Cash Flow | $-108,419 | $99,544 | $-97,807 | $69,955 | $-113,844 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 84,135 | N/A | N/A | N/A | 11,377 |
| Debt Repayment | -1,710 | -1,574 | -1,443 | -3,589 | -49,858 |
| Common Stock Issued | 202,270 | 1,084 | 38,109 | 160,781 | 181,496 |
| Common Stock Repurchased | -887 | -873 | -285 | -108 | -149 |
| Other Financing Activity | 0 | -26 | 0 | 0 | 0 |
| Financing Cash Flow | $283,808 | $-1,389 | $36,381 | $157,084 | $142,866 |
| Beginning Cash Position | 37,499 | 30,423 | 186,309 | 47,208 | 100,554 |
| End Cash Position | 137,266 | 37,499 | 30,423 | 186,309 | 47,208 |
| Net Cash Flow | $99,767 | $7,076 | $-155,886 | $139,101 | $-53,346 |
| Free Cash Flow | |||||
| Operating Cash Flow | -75,622 | -91,079 | -94,460 | -87,938 | -82,368 |
| Capital Expenditure | -80 | -1,721 | -492 | -1,206 | -1,132 |
| Free Cash Flow | -75,702 | -92,800 | -94,952 | -89,144 | -83,500 |